Some Problems Related to Risk-Benefit Assessments in Clinical Testing of New Vaccines

&
IRB: Ethics & Human Research 15 (1):1 (1993)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.2307/3564302

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,440

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Making Risk-Benefit Assessments of Medical Research Protocols.Alex Rajczi - 2004 - Journal of Law, Medicine and Ethics 32 (2):338-348.
Risk and medical ethics.E. Pochin - 1982 - Journal of Medical Ethics 8 (4):180-184.
Problems Related to Informed Consent from Young Teenagers Participating in Efficacy Testing of a New Vaccine.Gunnar Bjune & Øyvind Arnesen - 1992 - IRB: Ethics & Human Research 14 (5):6.
Toward a More Objective Understanding of the Evidence of Carcinogenic Risk.Deborah G. Mayo - 1988 - PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 1988:489 - 503.
Decision making in HIV testing among a group with low HIV risk.Adrian Coyle, Maria Knapp & Edmond O'Dea - 1996 - Journal of Evaluation in Clinical Practice 2 (3):223-230.
Ethically compromised vaccines and catholic teaching.Kevin McGovern & Brussen - 2011 - Chisholm Health Ethics Bulletin 17 (2):1.
Beyond Human Subjects: Risk, Ethics, and Clinical Development of Nanomedicines.Jonathan Kimmelman - 2012 - Journal of Law, Medicine and Ethics 40 (4):841-847.
Risk-Benefit Analysis: From a Logical Point of View. [REVIEW]Georg Spielthenner - 2012 - Journal of Bioethical Inquiry 9 (2):161-170.
The risk-benefit task of research ethics committees: An evaluation of current approaches and the need to incorporate decision studies methods. [REVIEW]Johannes J. M. Van Delden Rosemarie D. L. C. Bernabe, Ghislaine J. M. W. Van Thiel, Jan A. M. Raaijmakers - 2012 - BMC Medical Ethics 13 (1):6.
A call to restructure the drug development process: Government over-regulation and non-innovative late stage (phase III) clinical trials are major obstacles to advances in health care.Thomas C. Jones - 2005 - Science and Engineering Ethics 11 (4):575-587.
A new era in prenatal testing: are we prepared? [REVIEW]Dagmar Schmitz - 2013 - Medicine, Health Care and Philosophy 16 (3):357-364.
Social values and scientific evidence: The case of the HPV vaccines.Kristen Intemann & Inmaculada de Melo-Martín - 2010 - Biology and Philosophy 25 (2):203-213.
Is asio a good judge of character?Susan Gail Harris Rimmer - unknown
Challenges of genetic testing in adolescents with cardiac arrhythmia syndromes.Lilian Liou Cohen, Marina Stolerman, Christine Walsh, David Wasserman & Siobhan M. Dolan - 2012 - Journal of Medical Ethics 38 (3):163-167.

Analytics

Added to PP
2014-03-30

Downloads
15 (#953,629)

6 months
2 (#1,206,545)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references